GRAF FINCKENSTEIN FRIEDRICH sold IOVA
September 2, 2025 · Form 4 insider transaction
GRAF FINCKENSTEIN FRIEDRICH sold 8,790 shares of Iovance Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
8,790
Price
$0.00
Total value
N/A
InsiderGRAF FINCKENSTEIN FRIEDRICH
Role—
SecurityRestricted Stock Units
Transaction codeM: Option exercise
Transaction dateSeptember 2, 2025
Filing dateSeptember 4, 2025
Shares owned after52,738
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each RSU represents a contingent right to receive one share of the Issuer's common stock.; The remaining RSUs will vest in equal quarterly installments.; Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.